Li Q, Fu M, Kuang D, Pan C, et al. A Phase II Trial of Neoadjuvant Albumin-Bound Paclitaxel plus Carboplatin Combined with Tislelizumab in Locally Advanced HNSCC: Efficacy and Biomarker Exploration. Clin Cancer Res 2026;32:324-332.
PMID: 41252569